Motif ID: RFX7_RFX4_RFX1
Z-value: 1.516
Transcription factors associated with RFX7_RFX4_RFX1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
RFX1 | ENSG00000132005.4 | RFX1 |
RFX4 | ENSG00000111783.8 | RFX4 |
RFX7 | ENSG00000181827.10 | RFX7 |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.3 | GO:0033197 | response to vitamin E(GO:0033197) |
0.3 | 1.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 0.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 1.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.2 | 2.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.7 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.2 | 2.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.6 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 0.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 1.3 | GO:0060414 | aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 0.4 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.7 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.1 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.4 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.0 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 4.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.3 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.0 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0071883 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.4 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 1.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.2 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.0 | 0.7 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.2 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.1 | GO:0002887 | wound healing involved in inflammatory response(GO:0002246) negative regulation of myeloid leukocyte mediated immunity(GO:0002887) heme oxidation(GO:0006788) smooth muscle adaptation(GO:0014805) smooth muscle hyperplasia(GO:0014806) muscle hyperplasia(GO:0014900) negative regulation of leukocyte degranulation(GO:0043301) inflammatory response to wounding(GO:0090594) |
0.0 | 6.3 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0060119 | auditory receptor cell development(GO:0060117) inner ear receptor cell development(GO:0060119) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.2 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.1 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 1.2 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
0.0 | 0.1 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 2.2 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0090292 | nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) actin filament-based transport(GO:0099515) |
0.0 | 0.1 | GO:0045747 | auditory receptor cell differentiation(GO:0042491) positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.5 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.0 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.9 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) activation of cysteine-type endopeptidase activity(GO:0097202) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 1.6 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.0 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.1 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.7 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 1.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 2.0 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.5 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 4.1 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.7 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.2 | 0.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.5 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.2 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 1.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.0 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 1.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0004608 | phosphatidylethanolamine N-methyltransferase activity(GO:0004608) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 1.1 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 1.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.1 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.5 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.4 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | ST_ADRENERGIC | Adrenergic Pathway |